Drug companies have a 'target on their back and very few friends to protect them' after a shift from the Trump administration. 3 could be especially at risk.

This is a Business Insider Prime story. Click the link below to read it.

Read Full story

Add Comment()
Comments ()
Sort By:
Be the first one to comment.
We have sent you a verification email. This comment will be published once verification is done.